HaiYan Tu, Yong Wang, Hongxu Liu, Dingzhi Huang, Pei-Rong Ren, Fangling Ning, Xi Shi, Baogang Liu, Haiyan Yang, Lifeng Wang, Huijing Feng, Chunling Liu, Xian Zhong, Minghui Zhang, Yuping Sun, Aiqin Gao, Sujie Zhang, Jiaying Du, Jiawei Ye, Yi-Long Wu. "IBI363 (TAK-928) plus chemotherapy as first-line (1L) treatment for advanced non–small cell lung cancer (NSCLC).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.8586